Zdrowie i gospodarka · 26/06/2019

FDA Announces Draft Guidance for Clinical Investigations of Prostate Tissue Ablation Devices

The Food and Drug Administration (FDA) has released a draft guidance document outlining recommendations for clinical trials of high-intensity ultrasound systems for prostate tissue ablation and new ablation devices, which is now available for public review.